	US 12,404,498 B2
	Optimized parvovirus H-1 production
Barbara Leuchs, Heidelberg (DE); Veronika Frehtman, Heidelberg (DE); Marcus Müller, Bad Rappenau (DE); Jean Rommelaere, Heidelberg (DE); Michael Dahm, Munich (DE); and Ottheinz Krebs, Munich (DE)
Assigned to DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS, Heidelberg (DE)
Filed by DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS, Heidelberg (DE)
Filed on Dec. 6, 2021, as Appl. No. 17/542,721.
Application 17/542,721 is a continuation in part of application No. PCT/EP2020/066748, filed on Jun. 17, 2020.
Claims priority of application No. 19180628 (EP), filed on Jun. 17, 2019.
Prior Publication US 2022/0169992 A1, Jun. 2, 2022
Int. Cl. C12N 7/00 (2006.01); C12N 5/071 (2010.01)

CPC C12N 7/00 (2013.01) [C12N 5/0686 (2013.01); C12N 2750/14351 (2013.01); C12N 2750/14352 (2013.01)]

13 Claims

1. A MCS NB 324K cell; wherein cells designated MCS NB 324K that have uniform composition and are from a single source have been deposited with the German Collection of Microorganisms and Cell Cultures (DSMZ) under accession number DSM ACC3353.